Skip to content
Friday, 20 November 2026
BREAKING
HEALTH

India to Launch Its First Indigenous H5N1 Bird Flu Vaccine

Union Minister Shivraj Singh Chouhan will unveil Indias first indigenous H5N1 bird flu vaccine, a significant step for poultry health.

New Delhi, November 20 (Daily Kiran) : Union Agriculture Minister Shivraj Singh Chouhan is set to launch India’s first indigenous inactivated H5N1 highly pathogenic avian influenza (HPAI) virus vaccine for poultry on Friday. The initiative aims to bolster the country’s poultry sector against the deadly bird flu.

Developed by the ICAR-National Institute of High-Security Animal Diseases (NIHSAD) in Bhopal, this vaccine addresses a significant threat to chickens and other birds. The HPAI virus, commonly known as bird flu, poses a risk of mass mortality within flocks, leading to severe economic repercussions.

Bird flu outbreaks not only result in the death of numerous birds but also impose trade restrictions, disrupt international markets, and inflate poultry product prices, causing substantial financial losses for farmers. Since the first reported case in India in 2006, over 500 outbreaks of H5N1 and H5N8 subtypes have occurred.

Government estimates suggest that a major outbreak could reduce India’s GDP growth by 1.5% and jeopardize more than 20% of the country’s poultry population. The 2006 outbreak alone caused direct and indirect losses estimated between ₹22 billion to ₹30 billion. A separate outbreak in Manipur led to a loss equivalent to 0.5% of the state’s GDP.

In addition to economic losses, H5N1 poses a serious public health risk. According to the World Health Organization (WHO), there have been 1,003 reported human cases of H5N1 avian influenza across 25 countries since 2003, resulting in 479 fatalities. Most poultry outbreaks have been linked to the H5N1 clade 2.3.2.1a strain.

Recently, infections have also been detected in mammals, and three human cases have emerged. Until now, there was no specific commercial vaccine available to protect chickens from this strain. The indigenous vaccine developed by ICAR-NIHSAD aims to mitigate these risks, helping to safeguard chickens and reduce the economic impact on farmers, while also limiting the virus’s spread to other animals and humans.

Share